PRIMARY STUDY

Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence

Key Findings:  Results of this trial suggest that Δ8 -THCV may be a novel approach therapeutic approach for nicotine dependence. In addition, researchers suggest that THCV's ought to be tested for other potential anti-addiction efficacies.